ATRS

Antares Pharma, Inc.
ATRS

Overview Fund Activity
Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

164 hedge funds and large institutions have $181M invested in Antares Pharma, Inc. in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 56 reducing their positions, and 16 closing their positions.

Holders
164
Holders Change
+5
Holders Change %
+3.14%
% of All Funds
3.32%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
21
Increased
39
Reduced
56
Closed
16
Calls
$345K
Puts
$865K
Net Calls
-$520K
Net Calls Change
-$445K

Top Buyers

1
SCM
1
Stonepine Capital Management
Oregon
$3.26M
2
PAM
2
Panagora Asset Management
Massachusetts
$2.11M
3
SAM
3
Silvercrest Asset Management
New York
$6.57M
4
AC
4
Armistice Capital
New York
$1.16M
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.12M

Top Sellers

1
CWM
1
Centric Wealth Management
Illinois
$0
2
IECM
2
Intrinsic Edge Capital Management
Illinois
$0
3
QI
3
QS Investors
New York
$325K
4
State Street
4
State Street
Massachusetts
$11.3M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$3.59M
Name Holding Trade Value Shares
Change 		Shares
Change %
PP
176
PDS Planning
Ohio
– -$33K -12,000 Closed
CAN
177
Claraphi Advisory Network
United States
– -$28K -10,000 Closed
CFG
178
Citizens Financial Group
Rhode Island
– -$5K -1,742 Closed
OIA
179
Optimum Investment Advisors
Illinois
– -$3K -1,000 Closed
SSB
180
Sandy Spring Bank
Maryland
– -$3K -1,000 Closed
4 5 6 7
8